Tag: chemistry
-
Trial Shows Gel Clears Common Skin Cancer Wounds
Results of a clinical trial indicate a gel applied to lesions caused by basal cell carcinoma is safe for patients and clears the cancerous skin tumors.
-
Trial Shows Fast-Absorbing Opioid Overdose Nasal Swab
Results of a clinical trial show a nasal swab dispensing an opioid antidote transfers more of the antidote into the blood stream than syringe injections or nasal sprays.
-
Sustained-Released Eye Treatment Company Raises $11.9M
A company creating extended-release delivery techniques for eye therapies is raising $11.9 million in its first venture funding round.
-
Trial Shows Insulin Capsules Reduce Blood Glucose Levels
Results of a clinical trial reveal an optimal dose for an insulin capsule that in 12 weeks reduces blood glucose levels in patients with type 2 diabetes.
-
Biomarker-Guided Depression Drug Trial Underway
The first participant in a clinical trial received an experimental drug to treat patients with depression that express high levels of a stress-related protein.
-
Biotech, Regeneron in $2B Cancer Antibody Deal
A developer of cancer treatments triggered by tumor chemistry is partnering with biologic drug maker Regeneron on dual-action cancer immunotherapies.
-
Biotech, M.D. Anderson Partner on Precision Drug Design
A company discovering therapies with artificial intelligence is partnering with M.D. Anderson Cancer Center on new small-molecule precision medicines.
-
Companies to Partner on Sustainable Synthetic Biochemicals
A producer of plant-based organic acids and a developer of synthetic bio-based materials and services are partnering on new sustainable industrial chemicals.
-
Covid-19 Vaccine Patch Clinical Trial Begins
Developers of a patch with tiny needles instead of a syringe to deliver vaccines say a clinical trial testing a Covid-19 patch is now underway in Australia.
-
Cancer Detection Start-Up Gains $4M in Seed Funds
A developer of early-stage non-invasive cancer detection tests based on research in university labs is raising $4 million in its seed venture round.